Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,714.00
(
-1.73%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,073.25
(
-3.88%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 79154

Thursday, 06/11/2009 4:30:17 AM

Thursday, June 11, 2009 4:30:17 AM

Post# of 257257
MBRX sells its future considerations from AMP protein-kinase program to MRK for a paltry $6M:

http://finance.yahoo.com/news/Metabasis-Therapeutics-bw-15493604.html

Nice deal for MRK inasmuch as $6M is bus change for them. MBRX evidently needs the money to pay the gas and electric bills.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now